Literature DB >> 10771001

Transcriptional regulation of the human alpha5 nicotinic receptor subunit gene in neuronal and non-neuronal tissues.

A Flora1, R Schulz, R Benfante, E Battaglioli, S Terzano, F Clementi, D Fornasari.   

Abstract

The human alpha5 nicotinic receptor subunit gene appears to be expressed in several structures of the nervous system, but also in a number of non-neuronal tissues, with maximal expressions occurring in the entire gastrointestinal tract, thymus and testis. To understand whether specific transcriptional mechanisms are involved in the tissue-specific expression of the alpha5 subunit in neuronal and non-neuronal cells, we isolated the 5'-regulatory region of the human gene and characterized its functional properties. We demonstrate that specific DNA elements, with positive or negative activities depending on the cell type, are responsible for the diversified expression of the alpha5 subunit in different tissues. We therefore conclude that the expression of the alpha5 subunit relies on a highly complex promoter that uses distinct regulatory elements to comply with the different functional and developmental requirements of the various tissues and organs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771001     DOI: 10.1016/s0014-2999(00)00040-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

Review 2.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Authors:  Ma Reina D Improgo; Michael D Scofield; Andrew R Tapper; Paul D Gardner
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

3.  A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk.

Authors:  Chongjuan Wei; Younghun Han; Margaret R Spitz; Xifeng Wu; Haidee Chancoco; Pinchas Akiva; Gideon Rechavi; Hadar Brand; Issac Wun; Marsha L Frazier; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

4.  The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.

Authors:  Elizabeth S Barrie; Katherine Hartmann; Sung-Ha Lee; John T Frater; Michal Seweryn; Danxin Wang; Wolfgang Sadee
Journal:  Hum Mutat       Date:  2016-11-07       Impact factor: 4.878

5.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.

Authors:  Ming D Li; Qing Xu; Xiang-Yang Lou; Thomas J Payne; Tianhua Niu; Jennie Z Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

6.  Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology.

Authors:  Hiroshi Tsuneki; Ramiro Salas; John A Dani
Journal:  J Physiol       Date:  2002-12-20       Impact factor: 5.182

Review 7.  Nicotinic receptors as CNS targets for Parkinson's disease.

Authors:  Maryka Quik; Tanuja Bordia; Kathryn O'Leary
Journal:  Biochem Pharmacol       Date:  2007-06-17       Impact factor: 5.858

8.  Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence.

Authors:  J C Wang; R Grucza; C Cruchaga; A L Hinrichs; S Bertelsen; J P Budde; L Fox; E Goldstein; O Reyes; N Saccone; S Saccone; X Xuei; K Bucholz; S Kuperman; J Nurnberger; J P Rice; M Schuckit; J Tischfield; V Hesselbrock; B Porjesz; H J Edenberg; L J Bierut; A M Goate
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

9.  In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression.

Authors:  Glenn A Doyle; Min-Jung Wang; Andrew D Chou; John U Oleynick; Steven E Arnold; Russell J Buono; Thomas N Ferraro; Wade H Berrettini
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.